BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 46 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,658 | -1.5% | 50,882,000 | 0.0% | 0.07% | +9.5% |
| Q2 2023 | $51,406 | -4.2% | 50,882,000 | -0.6% | 0.06% | -10.0% |
| Q1 2023 | $53,645 | -94.7% | 51,188,000 | – | 0.07% | +6900.0% |
| Q1 2022 | $1,006,000 | -85.5% | 0 | -100.0% | 0.00% | -85.7% |
| Q4 2021 | $6,961,000 | -49.1% | 6,642,000 | -51.1% | 0.01% | -53.3% |
| Q3 2021 | $13,674,000 | -4.3% | 13,595,000 | -4.2% | 0.02% | -6.2% |
| Q2 2021 | $14,293,000 | – | 14,195,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 32,443,000 | $33,719,632 | 2.49% |
| MACKAY SHIELDS LLC | 76,393,000 | $80,060,298 | 2.20% |
| Lombard Odier Asset Management (Europe) Ltd | 15,560,000 | $16,178,043 | 0.80% |
| Sonora Investment Management Group, LLC | 7,840,000 | $8,152,676 | 0.71% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 25,220,000 | $26,430,712 | 0.50% |
| ZAZOVE ASSOCIATES LLC | 3,750,000 | $3,898 | 0.36% |
| LOOMIS SAYLES & CO L P | 2,059,347 | $200,251 | 0.35% |
| PIER 88 INVESTMENT PARTNERS LLC | 1,332,000 | $1,389,779 | 0.34% |
| Liberty Mutual Group Asset Management Inc. | 1,025,000 | $1,069 | 0.24% |
| RATIONAL ADVISORS LLC | 1,233,000 | $1,286,026 | 0.10% |